European cancer mortality predictions for the year 2013

M. Malvezzi, P. Bertuccio, F. Levi, C. La Vecchia, E. Negri

Research output: Contribution to journalArticle


Background: Estimated cancer mortality statistics were published for the years 2011 and 2012 for the European Union (EU) and its six more populous countries. Patients and methods: Using logarithmic Poisson count data joinpoint models and the World Health Organization mortality and population database, we estimated numbers of deaths and age-standardized (world) mortality rates (ASRs) in 2013 from all cancers and selected cancers. Results: The 2013 predicted number of cancer deaths in the EU is 1 314 296 (737 747 men and 576 489 women). Between 2009 and 2013, all cancer ASRs are predicted to fall by 6% to 140.1/100 000 in men, and by 4% to 85.3/ 100 000 in women. The ASRs per 100 000 are 6.6 men and 2.9 women for stomach, 16.7 men and 9.5 women for intestines, 8.0 men and 5.5 women for pancreas, 37.1 men and 13.9 women for lung, 10.5 men for prostate, 14.6 women for breast, and 4.7 for uterine cancer, and 4.2 and 2.6 for leukaemia. Recent trends are favourable except for pancreatic cancer and lung cancer in women. Conclusions: Favourable trends will continue in 2013. Pancreatic cancer has become the fourth cause of cancer death in both sexes, while in a few years lung cancer will likely become the first cause of cancer mortality in women as well, overtaking breast cancer.

Original languageEnglish
Article numbermdt010
Pages (from-to)792-800
Number of pages9
JournalAnnals of Oncology
Issue number3
Publication statusPublished - Mar 2013


  • Breast cancer
  • Cancer
  • Europe
  • Mortality
  • Projections
  • Time trends

ASJC Scopus subject areas

  • Oncology
  • Hematology

Fingerprint Dive into the research topics of 'European cancer mortality predictions for the year 2013'. Together they form a unique fingerprint.

  • Cite this

    Malvezzi, M., Bertuccio, P., Levi, F., La Vecchia, C., & Negri, E. (2013). European cancer mortality predictions for the year 2013. Annals of Oncology, 24(3), 792-800. [mdt010].